Nuveen’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $537M | Sell |
1,081,685
-2,810
| -0.3% | -$1.25M | 0.13% | 125 |
|
|
2026
Q1 | $484M | Buy |
1,084,495
+42,098
| +4% | +$19.6M | 0.13% | 137 |
|
|
2025
Q4 | $473M | Sell |
1,042,397
-35,313
| -3% | -$15.2M | 0.12% | 137 |
|
|
2025
Q3 | $422M | Buy |
1,077,710
+15,475
| +1% | +$6.47M | 0.11% | 157 |
|
|
2025
Q2 | $473M | Buy |
1,062,235
+63,817
| +6% | +$29.4M | 0.13% | 139 |
|
|
2025
Q1 | $484M | Sell |
998,418
-52,693
| -5% | -$24.6M | 0.15% | 133 |
|
|
2024
Q4 | $423M | Buy |
1,051,111
+261,891
| +33% | +$121M | 0.12% | 146 |
|
|
2024
Q3 | $367M | Sell |
789,220
-15,130
| -2% | -$7.27M | 0.1% | 165 |
|
|
2024
Q2 | $377M | Sell |
804,350
-31,367
| -4% | -$13.6M | 0.11% | 146 |
|
|
2024
Q1 | $349M | Sell |
835,717
-5,406
| -0.6% | -$2.29M | 0.1% | 170 |
|
|
2023
Q4 | $342M | Buy |
841,123
+28,536
| +4% | +$10.5M | 0.11% | 165 |
|
|
2023
Q3 | $283M | Sell |
812,587
-39,405
| -5% | -$13.8M | 0.1% | 182 |
|
|
2023
Q2 | $300M | Sell |
851,992
-56,336
| -6% | -$19M | 0.1% | 166 |
|
|
2023
Q1 | $286M | Sell |
908,328
-1,703
| -0.2% | -$511K | 0.11% | 175 |
|
|
2022
Q4 | $263M | Sell |
910,031
-424,810
| -32% | -$129M | 0.1% | 191 |
|
|
2022
Q3 | $386M | Buy |
1,334,841
+82,937
| +7% | +$23.9M | 0.16% | 130 |
|
|
2022
Q2 | $353M | Sell |
1,251,904
-5,830
| -0.5% | -$1.56M | 0.14% | 142 |
|
|
2022
Q1 | $315M | Sell |
1,257,734
-86,100
| -6% | -$20.4M | 0.1% | 187 |
|
|
2021
Q4 | $295M | Sell |
1,343,834
-21,391
| -2% | -$4.16M | 0.09% | 212 |
|
|
2021
Q3 | $248M | Sell |
1,365,225
-1,441,437
| -51% | -$281M | 0.08% | 233 |
|
|
2021
Q2 | $566M | Buy |
2,806,662
+63,271
| +2% | +$13.2M | 0.17% | 118 |
|
|
2021
Q1 | $590M | Buy |
2,743,391
+121,953
| +5% | +$26.8M | 0.19% | 110 |
|
|
2020
Q4 | $620M | Sell |
2,621,438
-880,517
| -25% | -$202M | 0.21% | 98 |
|
|
2020
Q3 | $953M | Buy |
3,501,955
+23,572
| +0.7% | +$6.5M | 0.37% | 58 |
|
|
2020
Q2 | $1.01B | Buy |
3,478,383
+726,720
| +26% | +$197M | 0.41% | 49 |
|
|
2020
Q1 | $655M | Buy |
2,751,663
+238,591
| +9% | +$54.7M | 0.32% | 69 |
|
|
2019
Q4 | $550M | Buy |
2,513,072
+445,821
| +22% | +$90.2M | 0.21% | 103 |
|
|
2019
Q3 | $350M | Sell |
2,067,251
-240,152
| -10% | -$42.5M | 0.14% | 144 |
|
|
2019
Q2 | $423M | Buy |
2,307,403
+2,292,058
| +14,937% | +$401M | 0.17% | 123 |
|
|
2019
Q1 | $2.82M | Sell |
15,345
-3
| -0% | -$554 | 0.02% | 596 |
|
|
2018
Q4 | $2.54M | Sell |
15,348
-108
| -0.7% | -$18.7K | 0.02% | 588 |
|
|
2018
Q3 | $2.98M | Sell |
15,456
-490
| -3% | -$87.3K | 0.02% | 601 |
|
|
2018
Q2 | $2.71M | Sell |
15,946
-2,375
| -13% | -$368K | 0.02% | 579 |
|
|
2018
Q1 | $2.99M | Sell |
18,321
-9,076
| -33% | -$1.48M | 0.02% | 542 |
|
|
2017
Q4 | $4.11M | Sell |
27,397
-61,138
| -69% | -$9.05M | 0.03% | 487 |
|
|
2017
Q3 | $13.5M | Sell |
88,535
-31,684
| -26% | -$4.77M | 0.09% | 328 |
|
|
2017
Q2 | $15.5M | Buy |
120,219
+53,439
| +80% | +$6.43M | 0.1% | 307 |
|
|
2017
Q1 | $7.3M | Buy |
66,780
+10,093
| +18% | +$889K | 0.04% | 473 |
|
|
2016
Q4 | $4.18M | Sell |
56,687
-125,609
| -69% | -$10.2M | 0.02% | 669 |
|
|
2016
Q3 | $15.9M | Buy |
182,296
+24,658
| +16% | +$2.33M | 0.09% | 258 |
|
|
2016
Q2 | $13.6M | Buy |
157,638
+141,721
| +890% | +$12.2M | 0.08% | 291 |
|
|
2016
Q1 | $1.27K | Sell |
15,917
-249
| -2% | -$22.5K | 0.01% | 935 |
|
|
2015
Q4 | $2.03K | Sell |
16,166
-892
| -5% | -$108K | 0.01% | 766 |
|
|
2015
Q3 | $1.78K | Buy |
17,058
+636
| +4% | +$81.7K | 0.01% | 807 |
|
|
2015
Q2 | $2.03K | Sell |
16,422
-29,355
| -64% | -$3.7M | 0.01% | 815 |
|
|
2015
Q1 | $5.4M | Sell |
45,777
-65,937
| -59% | -$7.9M | 0.03% | 511 |
|
|
2014
Q4 | $13.3M | Sell |
111,714
-127,854
| -53% | -$14.4M | 0.07% | 335 |
|
|
2014
Q3 | $26.9M | Buy |
239,568
+41,928
| +21% | +$3.99M | 0.17% | 158 |
|
|
2014
Q2 | $18.7M | Buy |
197,640
+160,450
| +431% | +$11.3M | 0.11% | 248 |
|
|
2014
Q1 | $2.63M | Sell |
37,190
-548
| -1% | -$43.4K | 0.02% | 704 |
|
|
2013
Q4 | $2.8M | Sell |
37,738
-14
| -0% | -$975 | 0.02% | 653 |
|
|
2013
Q3 | $2.86M | Sell |
37,752
-64,097
| -63% | -$5.1M | 0.02% | 667 |
|
|
2013
Q2 | $8.15M | Buy |
+101,849
| New | +$7.5M | 0.05% | 396 |
|
Other funds holding VRTX
Nuveen's VRTX Position: Q2 2026 in Review
Nuveen reduced its Vertex Pharmaceuticals (VRTX) stake by 0.26% in Q2 2026, selling an estimated $1.25M and leaving 1,081,685 shares worth $537M. The position accounts for 0.13% of the portfolio, ranked #125.
Nuveen first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.01B in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Nuveen held 1,081,685 shares of Vertex Pharmaceuticals worth $537M as of Q2 2026.
- Nuveen sold 2,810 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.25M.
- Vertex Pharmaceuticals made up 0.13% of Nuveen's portfolio in Q2 2026, its #125 holding.
- Nuveen first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Vertex Pharmaceuticals position peaked at $1.01B in Q2 2020.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.